Navigation Links
Operation makes dementia patients faster and smarter
Date:1/25/2011

Researchers from the University of Gothenburg and Sahlgrenska University Hospital are the first in the world to show that an operation can help patients with dementia caused by white matter changes and hydrocephalus.

Presented in the American Journal of Neurosurgery, the results are based on the world's first study to demonstrate the effects of a shunt operation using a placebo control. 14 patients were followed for an average of three and a half years after the operation, with half being given a non-functioning shunt in other words a sham operation and the other half a functioning shunt. This is the equivalent to the placebo given in drug trials to determine how much of the treatment's effect is down to the patient's and others' expectations.

"For obvious reasons, this is problematic in a surgical context and surgical placebo studies are highly unusual," says Magnus Tisell, docent at the Sahlgrenska Academy and consultant neurosurgeon at Sahlgrenska University Hospital. "However, if you can actually do this kind of study, the level of evidence is the highest possible class 1."

The researchers found that patients' mental functions and ability to walk improved tangibly after having a shunt inserted. Half were given an open shunt right from the start and showed immediate improvement, while the other half were initially given a closed shunt and improved only after three months when the shunt was opened.

"Shunt operations have long been used for hydrocephalus, but this study offers more scientifically conclusive results to support the effect of the treatment, and also shows that shunt operations can help far more patients than previously believed with their walking and memory," says Tisell.

Surgery is not generally used today for patients with hydrocephalus and white matter changes. But the researchers' findings pave the way for a brand new group of patients who could benefit from a shunt operation.

"We believe that far more patients than is currently the case could benefit from a shunt operation, which will require more resources," says Tisell. "We also need to find out more about which patients are good candidates for the operation and which shunt is best in each particular case."


'/>"/>

Contact: Magnus Tisell
magnus.tisell@vgregion.se
46-073-400-2029
University of Gothenburg
Source:Eurekalert

Related biology news :

1. Up to 20 million euros for Munich Catalysis research cooperation
2. Cooperation in diabetes research
3. John P. Holdren addresses climate change, stressing need for international cooperation
4. ARS, industry cooperation yields device to detect insects in stored wheat
5. Leading entomologist to give talk at UCR on communication and cooperation in ant societies
6. HFSP President Arima and Secretary General Winnacker awarded for fostering cooperation with China
7. Nanyang Technological University and UK partners heightens cooperation in water industry
8. Negligible impact on public safety from shark cage diving operations
9. Ovarian transplantation: New technique gives greatly improved results in this delicate operation
10. First riser-drilling research operations undertaken
11. Supply Chain Council Partners With APICS The Association for Operations Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/12/2017)... research undertaken by Fit Small Business has revealed ... simply asked which office technology had they not used in ... Insights on what will be key features in ... industry leaders including Penelope Trunk , Martin Lindstrom ... Some of these findings included; ...
(Date:1/6/2017)... JOLLA, Calif. , Jan. 6, 2017 /PRNewswire/ ... 1 safety studies in healthy volunteers of a ... intended to treat acute pancreatitis. ... is typically a mild disorder, but can be ... organ failure and sepsis, where extended hospital stays, ...
(Date:1/4/2017)... , Jan. 4, 2017  CES 2017 – ... sensor technology, today announced the launch of two ... systems, the highly-accurate biometric sensor modules that incorporate ... technology, experience and expertise. The two new designs ... specifically for hearables, and Benchmark BW2.0, a 2-LED ...
Breaking Biology News(10 mins):
(Date:1/21/2017)... -- Aratana Therapeutics, Inc. (NASDAQ: PETX ), ... and commercialization of innovative biopharmaceutical products for companion animals, ... North America 2016. ... the FDA approval of three innovative therapeutics in 2016, ... oral solution) and NOCITA ® (bupivacaine liposome injectable ...
(Date:1/20/2017)... http://www.Financialbuzz.com - According ... causes of death worldwide. There were 8.2 million cancer ... related deaths increased gradually over time, the death rates ... various cancers continues to drive demand of biological therapies ... Market Insights, Inc. cancer biological therapy market size was USD ...
(Date:1/19/2017)... 19, 2017 /PRNewswire -- WuXi AppTec, a leading ... and technology platform, today announced that it has ... preclinical drug discovery contract research organization (CRO). After ... wholly-owned subsidiary of WuXi, and will continue to ... greater services. The acquisition will further strengthen WuXi,s ...
(Date:1/19/2017)... , Jan. 19, 2017  ArmaGen, Inc., ... Schmidt , Ph.D., as chief executive officer, as ... directors. Dr. Schmidt brings to ArmaGen more than 17 ... research and development of biotherapeutics and pharmaceuticals. ... with the diverse experience and skillset necessary to ...
Breaking Biology Technology: